Cord Blood America, Inc., in support of its stated goal to become the most respected stem cell preservation company in the world, has selected a Los Angeles based public relations agency, Somerville Associates, to get the company’s message out. Cord Blood America provides families with the ability to preserve umbilical cord stem cells, which can be used by the family at a later date, if needed, to treat diseases and potentially save a family member’s life. The company feels that public education is, at this point, the most important thing they can do, and expects Somerville to play a key role in that effort.

Stem cells are increasingly seen as a valuable weapon in fighting a variety of diseases. The umbilical cord contains a rich store of stem cells, and provides a once-in-a-lifetime opportunity to capture and cryogenically preserve the cells for future use. As a result,

Proteonomix Inc. is a biotechnology company dedicated to the development of cell therapies to treat a wide variety of diseases. Headquartered in Mountainside, New Jersey, their current research is focused on cosmetics, antiaging, and injury. Through their subsidiary ProteoDERM, INC., they are commercializing their various products.

Their new line of anti-aging skin care products is now hitting the market. Their ProteoDERM Inc.’s anti-aging products are their Matrix NC-138 system of products. They sell the Matrix NC-138™ (3%) Serum, and a Day Cream SPF-25, Night Cream, a Gentle Cleanser, and a Gentle Exfoliator.

Proteonomix is also developing a platform for the growth of contaminant-free human embryonic stem (hES) cell lines. They will then make these available to the research community. They anticipate the commercialization of this product in the fourth quarter of this year. Proteonomix is working with leading scientists at prestigious institutions around the world to make tailored stem cell

Proteonomix Inc. is a biotechnology company dedicated to the development of cell therapies to treat a wide variety of diseases. Headquartered in Mountainside, New Jersey, their current research is focused on cosmetics, anti-aging, and injury. Through their subsidiary, ProteoDERM, INC., they are commercializing their various products.

Their new line of anti-aging skin care products is now hitting the market. These anti-aging products are the Matrix NC-138 system of products, sold as Matrix NC-138™ (3%) Serum, Day Cream SPF-25, Matrix Night Cream, a gentle cleanser and a gentle exfoliator.

Proteonomix is also developing a platform for the growth of contaminant-free human embryonic stem (hES) cell lines. They will then make these available to the research community. They anticipate the commercialization of this product in the fourth quarter of this year. Proteonomix is working with leading scientists at prestigious institutions around the world to make tailored stem cell therapies a reality.

The